Berríos ­Torres, S; Umscheid, C; Bratzler, D; Leas, B. et als.
JAMA Surg. 2017; 152(8): 784-­791

The human and financial costs of treating surgical site infections (SSIs) are increasing. The number of surgical procedures performed in the United States continues to rise, and surgical patients are initially seen with increasingly complex comorbidities. It is estimated that approximately half of SSIs are deemed preventable using evidence-based strategies.